Pre-2008 2008 2009 2010 2011 2012

A consistent pioneer in genomic software for core research, IP, and AG, GenomeQuest is now applying and expanding its technology to clinical genomics.

Close
TEDx Presentation GenomeQuest CEO Richard Resnick Presents at TEDx:
"The Next Hot Commodity of Genome Sequences"

"The worldwide capacity to sequence human genomes is something like 50 to 100 thousand human genomes this year. This is expected to double, triple, or maybe quadruple year over year for the foreseeable future." More

GenomeQuest Grants Six U.S. Labs Win Genomequest Grants to Advance to NGS Dx

GenomeQuest awarded six grants in software and services to help six laboratories facilitate the transition from multiple Sanger-based gene tests to consolidated next generation sequencing (NGS) based tests. More

Announcement of GQ-Dx GenomeQuest Announces Healthcare's First DSS for Whole Genome Diagnostics

Used to analyze and report information about variations in genes and proteins to improve disease treatment, the GQ-DxSM product will launch immediately for the scientific and clinical communities. More

Agricultural Syngenta Selects GenomeQuest as Data Platform for NGS

With GenomeQuest, Syngenta researchers can now pinpoint genes and variants that increase plant yield and improve plant protection as never before. More

Richard Resnick

Once Your Doctor Knows Your Genes, The Sick Become More Than Just A Disease

There are about 1,200 clinics across the United States that perform genetic tests today. Each one of these clinics examines a tiny portion of the genome [...]

More

Henk Heus, Ph.D.

Upcoming Improvements to the GenomeQuest Engine

As the product manager at GenomeQuest, I’m very excited to tell you about a couple of really great new features in the GQ-Engine.

More

Tony Flynn

CMDx - A Killer App for NGS

Diagnostics - specifically consolidated molecular testing (CMDx) - is a clear killer app for NGS. Labs and patients are realizing measurable rewards from faster/better/cheaper diagnostics for more and more diseases.

More

Nabil Hafez

Treatments not Terabytes

The genomics industry has a PR problem and it’s largely a self-made one. When I read articles about the latest in physics research and The Large Hadron Collider at CERN [...]

More